Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Current Assets (2016 - 2025)

STRATA Skin Sciences' Current Assets history spans 14 years, with the latest figure at $14.3 million for Q3 2025.

  • For Q3 2025, Current Assets fell 10.13% year-over-year to $14.3 million; the TTM value through Sep 2025 reached $14.3 million, down 10.13%, while the annual FY2024 figure was $16.6 million, 6.77% up from the prior year.
  • Current Assets for Q3 2025 was $14.3 million at STRATA Skin Sciences, up from $13.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $24.1 million in Q1 2021 and bottomed at $13.2 million in Q1 2024.
  • The 5-year median for Current Assets is $16.6 million (2024), against an average of $17.6 million.
  • The largest annual shift saw Current Assets plummeted 34.93% in 2024 before it rose 19.92% in 2025.
  • A 5-year view of Current Assets shows it stood at $20.0 million in 2021, then decreased by 24.63% to $15.1 million in 2022, then increased by 3.26% to $15.5 million in 2023, then rose by 6.77% to $16.6 million in 2024, then fell by 14.0% to $14.3 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Current Assets are $14.3 million (Q3 2025), $13.8 million (Q2 2025), and $15.9 million (Q1 2025).